Cargando…
P911: EVALUATION OF PROPHYLACTIC TOCILIZUMAB (TOCI) FOR THE REDUCTION OF CYTOKINE RELEASE SYNDROME (CRS) TO INFORM THE MANAGEMENT OF PATIENTS (PTS) TREATED WITH TECLISTAMAB IN MAJESTEC-1
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431116/ http://dx.doi.org/10.1097/01.HS9.0000970548.43149.cb |
| _version_ | 1785091123720486912 |
|---|---|
| author | van de Donk, Niels W.C.J. Garfall, Alfred Benboubker, Lotfi Uttervall, Katarina Groen, Kaz Rosiñol Dachs, Laura Hodin, Caroline Stephenson, Tara Trancucci, Danielle Perales-Puchalt, Alfredo Kobos, Rachel Banerjee, Arnob Mateos, Maria-Victoria |
| author_facet | van de Donk, Niels W.C.J. Garfall, Alfred Benboubker, Lotfi Uttervall, Katarina Groen, Kaz Rosiñol Dachs, Laura Hodin, Caroline Stephenson, Tara Trancucci, Danielle Perales-Puchalt, Alfredo Kobos, Rachel Banerjee, Arnob Mateos, Maria-Victoria |
| author_sort | van de Donk, Niels W.C.J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431116 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104311162023-08-17 P911: EVALUATION OF PROPHYLACTIC TOCILIZUMAB (TOCI) FOR THE REDUCTION OF CYTOKINE RELEASE SYNDROME (CRS) TO INFORM THE MANAGEMENT OF PATIENTS (PTS) TREATED WITH TECLISTAMAB IN MAJESTEC-1 van de Donk, Niels W.C.J. Garfall, Alfred Benboubker, Lotfi Uttervall, Katarina Groen, Kaz Rosiñol Dachs, Laura Hodin, Caroline Stephenson, Tara Trancucci, Danielle Perales-Puchalt, Alfredo Kobos, Rachel Banerjee, Arnob Mateos, Maria-Victoria Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431116/ http://dx.doi.org/10.1097/01.HS9.0000970548.43149.cb Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters van de Donk, Niels W.C.J. Garfall, Alfred Benboubker, Lotfi Uttervall, Katarina Groen, Kaz Rosiñol Dachs, Laura Hodin, Caroline Stephenson, Tara Trancucci, Danielle Perales-Puchalt, Alfredo Kobos, Rachel Banerjee, Arnob Mateos, Maria-Victoria P911: EVALUATION OF PROPHYLACTIC TOCILIZUMAB (TOCI) FOR THE REDUCTION OF CYTOKINE RELEASE SYNDROME (CRS) TO INFORM THE MANAGEMENT OF PATIENTS (PTS) TREATED WITH TECLISTAMAB IN MAJESTEC-1 |
| title | P911: EVALUATION OF PROPHYLACTIC TOCILIZUMAB (TOCI) FOR THE REDUCTION OF CYTOKINE RELEASE SYNDROME (CRS) TO INFORM THE MANAGEMENT OF PATIENTS (PTS) TREATED WITH TECLISTAMAB IN MAJESTEC-1 |
| title_full | P911: EVALUATION OF PROPHYLACTIC TOCILIZUMAB (TOCI) FOR THE REDUCTION OF CYTOKINE RELEASE SYNDROME (CRS) TO INFORM THE MANAGEMENT OF PATIENTS (PTS) TREATED WITH TECLISTAMAB IN MAJESTEC-1 |
| title_fullStr | P911: EVALUATION OF PROPHYLACTIC TOCILIZUMAB (TOCI) FOR THE REDUCTION OF CYTOKINE RELEASE SYNDROME (CRS) TO INFORM THE MANAGEMENT OF PATIENTS (PTS) TREATED WITH TECLISTAMAB IN MAJESTEC-1 |
| title_full_unstemmed | P911: EVALUATION OF PROPHYLACTIC TOCILIZUMAB (TOCI) FOR THE REDUCTION OF CYTOKINE RELEASE SYNDROME (CRS) TO INFORM THE MANAGEMENT OF PATIENTS (PTS) TREATED WITH TECLISTAMAB IN MAJESTEC-1 |
| title_short | P911: EVALUATION OF PROPHYLACTIC TOCILIZUMAB (TOCI) FOR THE REDUCTION OF CYTOKINE RELEASE SYNDROME (CRS) TO INFORM THE MANAGEMENT OF PATIENTS (PTS) TREATED WITH TECLISTAMAB IN MAJESTEC-1 |
| title_sort | p911: evaluation of prophylactic tocilizumab (toci) for the reduction of cytokine release syndrome (crs) to inform the management of patients (pts) treated with teclistamab in majestec-1 |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431116/ http://dx.doi.org/10.1097/01.HS9.0000970548.43149.cb |
| work_keys_str_mv | AT vandedonknielswcj p911evaluationofprophylactictocilizumabtociforthereductionofcytokinereleasesyndromecrstoinformthemanagementofpatientsptstreatedwithteclistamabinmajestec1 AT garfallalfred p911evaluationofprophylactictocilizumabtociforthereductionofcytokinereleasesyndromecrstoinformthemanagementofpatientsptstreatedwithteclistamabinmajestec1 AT benboubkerlotfi p911evaluationofprophylactictocilizumabtociforthereductionofcytokinereleasesyndromecrstoinformthemanagementofpatientsptstreatedwithteclistamabinmajestec1 AT uttervallkatarina p911evaluationofprophylactictocilizumabtociforthereductionofcytokinereleasesyndromecrstoinformthemanagementofpatientsptstreatedwithteclistamabinmajestec1 AT groenkaz p911evaluationofprophylactictocilizumabtociforthereductionofcytokinereleasesyndromecrstoinformthemanagementofpatientsptstreatedwithteclistamabinmajestec1 AT rosinoldachslaura p911evaluationofprophylactictocilizumabtociforthereductionofcytokinereleasesyndromecrstoinformthemanagementofpatientsptstreatedwithteclistamabinmajestec1 AT hodincaroline p911evaluationofprophylactictocilizumabtociforthereductionofcytokinereleasesyndromecrstoinformthemanagementofpatientsptstreatedwithteclistamabinmajestec1 AT stephensontara p911evaluationofprophylactictocilizumabtociforthereductionofcytokinereleasesyndromecrstoinformthemanagementofpatientsptstreatedwithteclistamabinmajestec1 AT trancuccidanielle p911evaluationofprophylactictocilizumabtociforthereductionofcytokinereleasesyndromecrstoinformthemanagementofpatientsptstreatedwithteclistamabinmajestec1 AT peralespuchaltalfredo p911evaluationofprophylactictocilizumabtociforthereductionofcytokinereleasesyndromecrstoinformthemanagementofpatientsptstreatedwithteclistamabinmajestec1 AT kobosrachel p911evaluationofprophylactictocilizumabtociforthereductionofcytokinereleasesyndromecrstoinformthemanagementofpatientsptstreatedwithteclistamabinmajestec1 AT banerjeearnob p911evaluationofprophylactictocilizumabtociforthereductionofcytokinereleasesyndromecrstoinformthemanagementofpatientsptstreatedwithteclistamabinmajestec1 AT mateosmariavictoria p911evaluationofprophylactictocilizumabtociforthereductionofcytokinereleasesyndromecrstoinformthemanagementofpatientsptstreatedwithteclistamabinmajestec1 |